FairValueLabs Valuation System Pure Speculation
CRWV

CoreWeave, Inc. (CRWV) Stock Analysis — Fair Value, Risk & Moat Rating

NMS · Technology · Software - Infrastructure

$105.26 Watch — Analyst Anchor -1.03 (-1.0%) As of Aug 13, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict High Risk
0.57
Altman Z-ScoreDistress Zone
N/A
Fair ValueNot applicable — speculation
2.9
Moat RatingNarrow moat · eroding
TL;DR · Audit Summary

Is CoreWeave, Inc. a safe investment right now?

As of Aug 13, 2026, our estimated fair value (intrinsic value) for CoreWeave, Inc. (CRWV) stock is $141.83, versus a market price of $105.26 — Watch — Analyst Anchor. Analyst Consensus (35 analysts) — EPS model not applicable at negative earnings.

CoreWeave, Inc.'s Altman Z-Score of 0.57 places it in the distress zone. Our fair value estimate is $141.83 (Watch — Analyst Anchor). Moat rating: 2.9/5 stars.

CoreWeave, Inc. is part of the Cloud Hyperscalers & Frontier Infrastructure group in our AI coverage — compare its fair value against every other AI, cloud, and quantum stock through a value investing lens.

Price Chart · CRWV
Section 01 · Financial Health

Could CoreWeave, Inc. go bankrupt? Altman Z-Score analysis

0.57

Z-Score of 0.57 falls below the 1.8 distress threshold, indicating significant financial stress.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives CRWV's Z-Score?

Altman Z-Score components for CRWV
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA-0.18161.2-0.22
B · Retained Earnings / Total AssetsRE / TA-0.05361.4-0.08
C · EBIT / Total AssetsEBIT / TA0.00033.30.0
D · Market Cap / Total LiabilitiesMCap / TL1.2630.60.76
E · Revenue / Total AssetsRev / TA0.10411.00.1

How has CRWV's financial health changed over time?

3.0 Safe1.8 Distress0.01.63.24.96.5202320242025
CRWV Z-Score history
YearZ-ScoreZone
20235.65Safe
20241.62Distress
20250.57Distress

Source: Calculated from CRWV's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

CoreWeave, Inc. Fair Value & Intrinsic Value — What Is It Actually Worth?

FVL Fair Value$141.83
vs
Market Price$105.26
Watch — Analyst Anchor 25.8% Analyst consensus target is 25.8% above the current price. This is a consensus anchor for a loss-making company — not a value-model rating.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$0.00Proprietary blend of reported actuals + analyst consensus, weighted by α
Trailing P/E0.0xCurrent market pricing
Fair P/E (β discount)0.0xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)N/ADirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $141.83 (35 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does CoreWeave, Inc. have a durable competitive advantage?

★★½☆☆
Narrow moat · eroding

Moat rating: 2.9/5.

What makes up CRWV's moat score?

ROIC Stability

★★☆☆☆

ROIC variability over the past decade. Score: 2/5.

Gross Margin Trend

★★★★☆

Gross margin trajectory over the past decade. Score: 4/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is CRWV's return on invested capital?

0%-62%-44%-26%-8%10%202320242025
CRWV ROIC history
YearROICTrend
2023-57.2%
2024-5.1%Rising
20250.1%Rising

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is CoreWeave, Inc.'s dividend safe?

Status Suspended CoreWeave, Inc. has suspended its dividend. No payout is currently being made to shareholders.
Section 05 · Financial Summary

CoreWeave, Inc.'s key financial metrics

CRWV financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $5.1B $1.9B $0.0B Rising
Net Income −$1.2B −$0.9B −$0.0B Declining
Free Cash Flow −$7.3B −$6.0B −$0.1B Declining
Gross Margin 71.7% 74.3% 23.4% Rising
Section 06 · Lab Signals

Recent events that affect our CRWV analysis

EARNINGS

CRWV earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $-1.20. Revenue estimate: $2.56B. Our current Fair Value: $141.83 — a significant beat or miss could shift this estimate.

ANALYST

CRWV analyst consensus: 71% bullish (27 of 38 analysts)

Lab Impact

6 Strong Buy, 21 Buy, 9 Hold, 1 Sell, 1 Strong Sell. Consensus target: $141.83 (34.7% upside). Compare with our independent Fair Value: $141.83.

FILING

CRWV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CRWV beat EPS estimates by 22.4%

Lab Impact

Reported EPS: $-1.14 vs estimate $-1.47. Earnings strength supports our Fair Value of $141.83 (34.7% above current price).

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CRWV missed EPS estimates by 22.4%

Lab Impact

Reported EPS: $-1.12 vs estimate $-0.91. Our Fair Value of $141.83 may face downward pressure if the trend continues.

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

CRWV missed EPS estimates by 30.0%

Lab Impact

Reported EPS: $-0.89 vs estimate $-0.68. Our Fair Value of $141.83 may face downward pressure if the trend continues.

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CRWV beat EPS estimates by 54.4%

Lab Impact

Reported EPS: $-0.22 vs estimate $-0.48. Earnings strength supports our Fair Value of $141.83 (34.7% above current price).

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CRWV missed EPS estimates by 21.7%

Lab Impact

Reported EPS: $-0.60 vs estimate $-0.49. Our Fair Value of $141.83 may face downward pressure if the trend continues.

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

CRWV missed EPS estimates by 538.4%

Lab Impact

Reported EPS: $-1.40 vs estimate $-0.22. Our Fair Value of $141.83 may face downward pressure if the trend continues.

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CRWV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about CoreWeave, Inc.

What is CoreWeave, Inc. stock price today?

CoreWeave, Inc. (CRWV) stock price is $105.26 as of the latest market close, traded on the NASDAQ exchange.

What does CoreWeave, Inc. do?

CoreWeave, Inc. operates as a cloud infrastructure technology company in the United States. It offers CoreWeave Cloud platform that comprises proprietary software and cloud services that deliver the automation and efficiency needed to manage complex artificial intelligence (AI) infrastructure at scale.

What is CoreWeave, Inc. market cap?

CoreWeave, Inc. has a market capitalization of $58.05B, classifying it as a large-cap stock in the Technology sector.

What sector and industry is CRWV in?

CoreWeave, Inc. operates in the Technology sector, specifically within the Software - Infrastructure industry. It trades on the NASDAQ under the ticker symbol CRWV.

Is CRWV stock overvalued or undervalued?

Based on our valuation model, CoreWeave, Inc. trades 25.8% below our fair value estimate — potentially undervalued.

  • FairValueLabs Fair Value: $141.83
  • Current Price: $105.26
  • Valuation Zone: Watch — Analyst Anchor
What is CRWV stock forecast and analyst target price?

Based on 35 Wall Street analysts, the consensus price target for CoreWeave, Inc. is $141.83, implying upside of 34.7% from the current price.

  • Analyst High Target: $303.00
  • Analyst Low Target: $36.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is CoreWeave, Inc. revenue and earnings growing?

Here are the analyst consensus growth estimates for CoreWeave, Inc.:

  • Revenue growth (current year est.): 149.0%
  • EPS growth (current year est.): -87.4%
  • Revenue growth (next year est.): 103.2%
  • EPS growth (next year est.): 20.2%
What are CoreWeave, Inc.'s key financial metrics?
MetricLatestTrend
Revenue$5.1BRising
Net Income−$1.2BDeclining
Free Cash Flow−$7.3BDeclining
Gross Margin71.7%Rising
What is CRWV's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Forward P/E (next 12 months est.): -62.1x
How volatile is CRWV stock?

CoreWeave, Inc. has a beta of 1.00, meaning it is roughly in line with overall market volatility. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does CoreWeave, Inc. have?

CoreWeave, Inc.'s balance sheet shows:

  • Total Cash: $5.54B
  • Total Debt: $51.61B
  • Net Cash Position: $-46.07B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is CoreWeave, Inc.'s free cash flow?

CoreWeave, Inc. generated $-9.09B in trailing twelve-month free cash flow (from $6.91B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does CoreWeave, Inc. pay a dividend?

CoreWeave, Inc. does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.

Is CoreWeave, Inc. at risk of going bankrupt?

CoreWeave, Inc.'s Altman Z-Score is 0.57, placing it in the distress zone (below 1.8) — elevated bankruptcy risk. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does CoreWeave, Inc. have a durable competitive advantage?

CoreWeave, Inc. scores 2.9/5 stars (Narrow moat · eroding) in our moat analysis:

  • ROIC Stability: 2/5
  • Gross Margin Trend: 4/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is CRWV's return on equity (ROE)?

CoreWeave, Inc.'s return on equity is -43.6%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy CRWV stock?

CRWV shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol CRWV
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is CRWV a value stock or speculative?

FairValueLabs classifies CoreWeave, Inc. as Pure Speculation. It lacks the financial stability or valuation margin typically required for value investing. This stock is considered high risk.

Who is the CEO of CoreWeave, Inc.?

The current CEO of CoreWeave, Inc. is Mr. Michael N. Intrator.

What is CRWV's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $-3.55
  • Forward EPS (next 12 months est.): $-1.70
  • Analyst consensus EPS (this year): $-5.15
  • Analyst consensus EPS (next year): $-4.11

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Aug 13, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

CRWV analysis methodology: How we calculate fair value, Z-Scores, and moat ratings